Core Viewpoint - Hims & Hers Health is acquiring Australian digital health service provider Eucalyptus for a total transaction value of up to $1.15 billion, which is expected to enhance its market presence in Australia and Japan, while expanding operations in the UK, Germany, and Canada [1] Group 1: Acquisition Details - The acquisition will involve a cash payment of approximately $240 million, with Eucalyptus eligible for deferred performance payments over the next 18 months, potentially receiving additional payments based on financial targets by early 2029 [1] - Hims has the option to pay a significant portion of the deferred and performance payments in cash or stock [1] Group 2: Financial Impact and Market Strategy - Eucalyptus, based in Sydney, has an annual revenue exceeding $450 million, making it the largest digital health service provider in Australia [1] - The funding for this transaction is expected to come primarily from Hims' existing cash reserves and operational cash flow from its U.S. business [1] - The transaction is anticipated to be completed by mid-2026 [1]